no image available Dickens & Co. "A New Hope for Rheumatoid Arthritis: Exploring the Efficacy of a Third Tumor Necrosis Factor Blocking Agent" "A Study on the Effectiveness of Adalimumab as a Ladder to Treating Refractory Rheumatoid Arthritis" Price: 25.00€